December 2008 A U.S. FDA advisory panel reviewed Eli Lilly's and Daiichi Sankyo's blood-clot preventer prasugrel, adding a new hurdle for approval of the potential blockbuster medicine.
THIS WEBSITE TALKS ABOUT THE SIDE EFFECTS AND THE POTENTIAL HEALTH BENEFITS OF HERBS, SUPPLEMENTS,